PMA P080004S043

Device
iSert® Pre-loaded System; IPURE Pre-loaded System; PreVue Pre-loaded System
Applicant
Hoya Surgical Optics, Inc.
PMA number
P080004
Supplement
S043
Product code
HQL
Decision date
2021-12-28
Generic name
intraocular lens
Approval order statement
Approval for nine (9) changes to the routine Ethylene Oxide (EO) sterilization process, including:1) The sterilization equipment used in your routine EO sterilization process;2) the implementation of a unified set of EO sterilization process parameters for your US marketed products;3) the lower control limit for EO gas used in your routine EO sterilization process;4) the method for monitoring EO gas concentration;5) the frequency of EO sterilant residuals testing; 6) the Process Challenge Device (PCD) used during routine EO sterilization cycles and validation activities;7) the number of PCDs used during routine EO sterilization cycles and validation activities;8) the approach used for validation/re-validation activities; and9) the re-validation cycle.

Current openFDA PMA Record#

Device
iSert® Pre-loaded System; IPURE Pre-loaded System; PreVue Pre-loaded System
Applicant
Hoya Surgical Optics, Inc.
PMA number
P080004
Supplement
S043
Product code
HQL
Generic name
intraocular lens
Decision date
2021-12-28
Decision code
APPR
Date received
2021-10-04
Supplement type
Real-Time Process
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for nine (9) changes to the routine Ethylene Oxide (EO) sterilization process, including:1) The sterilization equipment used in your routine EO sterilization process;2) the implementation of a unified set of EO sterilization process parameters for your US marketed products;3) the lower control limit for EO gas used in your routine EO sterilization process;4) the method for monitoring EO gas concentration;5) the frequency of EO sterilant residuals testing; 6) the Process Challenge Device (PCD) used during routine EO sterilization cycles and validation activities;7) the number of PCDs used during routine EO sterilization cycles and validation activities;8) the approach used for validation/re-validation activities; and9) the re-validation cycle.